Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

YALE UNIVERSITY

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1701-10-09

Employees: 10K

Market Cap: -

Website: http://www.yale.edu

Clinical Trials

Phase 2 Study of Neoadjuvant Vemurafenib in Melanoma Patients With Untreated Brain Metastases

Phase 2

Completed

Conditions: Melanoma

Interventions: Drug: Vemurafenib

First Posted Date: 2013-01-31

Last Posted Date: 2017-03-10

Lead Sponsor: Yale University

Target Recruit Count: 2

Registration Number: NCT01781026

Locations: 🇺🇸
Smilow Cancer Hospital at Yale New Haven, New Haven, Connecticut, United States

Handheld Technology for Speech Development in Students With Autism

Not Applicable

Completed

Conditions: Autism Spectrum Disorders

Interventions: Other: iPad software

First Posted Date: 2013-01-30

Last Posted Date: 2013-01-30

Lead Sponsor: Yale University

Target Recruit Count: 40

Registration Number: NCT01780090

Locations: 🇺🇸
Yale Child Study Center, New Haven, Connecticut, United States

Trial of Ketamine and Lithium Therapy in Bipolar Depression

Phase 2

Withdrawn

Conditions: Bipolar Depression

Interventions: Drug: Placebo
Drug: Ketamine/Lithium
Drug: Ketamine

First Posted Date: 2013-01-15

Last Posted Date: 2023-03-01

Lead Sponsor: Yale University

Registration Number: NCT01768767

SILVER-AMI: Outcomes in Older Persons With Heart Attacks

Completed

Conditions: Acute Myocardial Infarction

First Posted Date: 2012-12-21

Last Posted Date: 2019-05-28

Lead Sponsor: Yale University

Target Recruit Count: 3042

Registration Number: NCT01755052

Locations: 🇺🇸
Meritus Medical Center, Hagerstown, Maryland, United States
🇺🇸
Mission Medical Associates, Inc. dba Asheville Cardiology Associates, Asheville, North Carolina, United States
🇺🇸
Emory University, Atlanta, Georgia, United States

and more 78 locations

3-D Imaging Assessment of Scar Formation and Would Healing in Fat Grafted vs Non-Fat Grafted Facial Reconstruction Wound Sites

Phase 1

Withdrawn

Conditions: Scar Formation
Autologous Fat Grafting

Interventions: Procedure: Autologous Fat Grafting
Other: No intervention

First Posted Date: 2012-12-17

Last Posted Date: 2016-09-05

Lead Sponsor: Yale University

Registration Number: NCT01750424

Locations: 🇺🇸
Yale University School of Medicine, New Haven, Connecticut, United States

A Comparative Study of Occlusive Heat Patch in the Treatment of Warts

Not Applicable

Completed

Conditions: Verruca (Warts)

Interventions: Device: Occlusive Heat Patch

First Posted Date: 2012-12-10

Last Posted Date: 2022-11-15

Lead Sponsor: Yale University

Target Recruit Count: 73

Registration Number: NCT01746056

Locations: 🇺🇸
Yale School of Medicine, New Haven, Connecticut, United States

An Open Label, International, Multi-centre, Phase I/IIa Study of Lenalidomide (Revlimid) and Romidepsin (Istodax) for Relapsed /Refractory Hodgkin Lymphoma, Mature T-cell Lymphoma and Multiple Myeloma. (RId Study)

Phase 1

Terminated

Conditions: Mature T-cell Lymphoma
Multiple Myeloma
Hodgkin's Lymphoma

Interventions: Drug: lenalidomide (Revlimid) and romidepsin (Istodax)

First Posted Date: 2012-12-05

Last Posted Date: 2020-03-04

Lead Sponsor: Yale University

Target Recruit Count: 12

Registration Number: NCT01742793

Locations: 🇺🇸
Yale Cancer Center, New Haven, Connecticut, United States

Does Doxazosin Attenuate Stress-induced Smoking and Improve Clinical Outcomes?

Phase 2

Completed

Conditions: Smoking

Interventions: Drug: Placebo
Drug: Doxazosin 8mg/day
Drug: Doxazosin 4mg/day

First Posted Date: 2012-11-21

Last Posted Date: 2018-02-20

Lead Sponsor: Yale University

Target Recruit Count: 35

Registration Number: NCT01730846

Locations: 🇺🇸
Yale Center for Clinical Investigations, Yale University, New Haven, Connecticut, United States

Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning

Recruiting

Conditions: Schizophrenia
Post Traumatic Stress Disorder
Cannabis Dependence
Prodromal for Psychotic Illness
Opioid-use Disorder
Family History of Alcoholism
Healthy Control

Interventions: Radiation: [11-C]OMAR

First Posted Date: 2012-11-21

Last Posted Date: 2025-04-09

Lead Sponsor: Yale University

Target Recruit Count: 100

Registration Number: NCT01730781

Locations: 🇺🇸
Connecticut Mental Health Center, Clinical Neuroscience Research Unit, New Haven, Connecticut, United States

Hepatic De Novo Lipogenesis (DNL)in the Pathogenesis of Hepatic Steatosis in Obese Youth

Completed

Conditions: Fatty Liver
Hepatic Steatosis

First Posted Date: 2012-11-12

Last Posted Date: 2023-06-15

Lead Sponsor: Yale University

Target Recruit Count: 60

Registration Number: NCT01725035

Locations: 🇺🇸
Yale University, New Haven, Connecticut, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy